Grail Inc Asset Turnover Ratio (GRAL), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Grail Inc   (NASDAQ: GRAL)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Grail Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Grail Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.06 in the second quarter (Jun 30 2026)

Within sector 5 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 1261, from total ranking in the first quarter 2026 at 1311.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GRAL Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 5.22 % -1.55 % -2.05 % -16.58 % -17.34 %
Y / Y Revenue Change 25.72 % 28.11 % 13.97 % 26.32 % 11.18 %
Asset Turnover Ratio (TTM) 0.06 0.06 0.05 0.05 0.05
GRAL's Total Ranking # 1261 # 1311 # 1190 # 3025 #
Seq. Asset Change 1.43 % -4.06 % 12.34 % -3.76 % -5.09 %
Seq. Revenue Change 9.57 % -6.45 % 20.45 % 1.83 % 11.64 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 131
Overall Market # 1261

Asset Turnover Ratio Statistics
High Average Low
3996.25 675.02 8.39
(Jun 30 2024)   (Dec 31 2025)




GRAL Company Profile • Back to GRAL Efficiency Comparisons • Compare GRAL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Skinvisible Inc   0.16 $ 0.020  Millions$ 0.126  Millions
Maxcyte inc   0.16 $ 31.051  Millions$ 198.782  Millions
Abeona Therapeutics Inc   0.15 $ 30.093  Millions$ 207.166  Millions
Voyager Therapeutics Inc   0.14 $ 34.459  Millions$ 239.417  Millions
Standard Biotools Inc   0.14 $ 83.691  Millions$ 593.430  Millions
Femasys Inc   0.14 $ 2.299  Millions$ 16.450  Millions
Seastar Medical Holding Corp  0.14 $ 1.713  Millions$ 12.400  Millions
Sintx Technologies Inc   0.14 $ 1.330  Millions$ 9.778  Millions
Lucid Diagnostics Inc   0.13 $ 5.445  Millions$ 41.667  Millions
Omniab Inc   0.13 $ 38.457  Millions$ 298.628  Millions
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
Kura Oncology Inc   0.12 $ 77.225  Millions$ 657.022  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
C4 Therapeutics Inc   0.11 $ 35.039  Millions$ 328.207  Millions
Scilex Holding Company  0.11 $ 31.608  Millions$ 297.014  Millions
Ginkgo Bioworks Holdings Inc   0.10 $ 111.863  Millions$ 1,082.996  Millions
Zymeworks Inc   0.09 $ 37.127  Millions$ 404.744  Millions
Nektar Therapeutics  0.09 $ 54.589  Millions$ 610.038  Millions
Bolt Biotherapeutics Inc   0.09 $ 4.700  Millions$ 52.543  Millions
Therapeuticsmd Inc   0.09 $ 3.270  Millions$ 37.859  Millions
Lenz Therapeutics Inc   0.08 $ 21.475  Millions$ 256.428  Millions
Lipocine Inc   0.08 $ 1.569  Millions$ 20.568  Millions
Longeveron Inc   0.08 $ 1.187  Millions$ 15.629  Millions
Armata Pharmaceuticals Inc   0.07 $ 6.034  Millions$ 81.537  Millions
Catheter Precision Inc   0.07 $ 1.915  Millions$ 28.322  Millions
Metagenomi Therapeutics Inc   0.06 $ 13.561  Millions$ 209.924  Millions
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.